(S (NP (NP (DT The) (NN identification)) (PP (IN of) (NP (JJ novel) (NN drug-target) (PRN (-LRB- -LRB-) (NNP DT) (-RRB- -RRB-)) (NNS interactions)))) (VP (VBZ is) (NP (NP (DT a) (JJ substantial) (NN part)) (PP (IN of) (NP (DT the) (NN drug) (NN discovery) (NN process))))) (. .))
(S (NP (NP (JJS Most)) (PP (IN of) (NP (NP (DT the) (JJ computational) (NNS methods)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN proposed) (S (VP (TO to) (VP (VB predict) (NP (NNP DT) (NNS interactions))))))))))))) (VP (VBP have) (VP (VBN focused) (PP (IN on) (NP (NP (JJ binary) (NN classification)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN goal)) (VP (VBZ is) (S (VP (TO to) (VP (VB determine) (SBAR (SBAR (IN whether) (S (NP (DT a) (NNP DT) (NN pair)) (VP (NNS interacts)))) (CC or) (RB not)))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (S (NP (JJ protein-ligand) (NNS interactions)) (VP (VBP assume) (NP (NP (DT a) (NN continuum)) (PP (IN of) (NP (NP (VBG binding) (NN strength) (NNS values)) (, ,) (VP (ADVP (RB also)) (VBD called) (S (NP (VBG binding) (NN affinity))))))))) (CC and) (S (S (VP (VBG predicting) (NP (DT this) (NN value)))) (ADVP (RB still)) (VP (VBZ remains) (NP (DT a) (NN challenge)))) (. .))
(S (NP (NP (DT The) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN affinity) (NNS data)) (ADJP (JJ available) (PP (IN in) (NP (NNP DT) (NNS knowledge-bases))))))) (VP (VBZ allows) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (JJ advanced) (VBG learning) (NNS techniques)) (PP (JJ such) (IN as) (NP (JJ deep) (NN learning) (NNS architectures))))) (PP (IN in) (NP (NP (DT the) (NN prediction)) (PP (IN of) (NP (VBG binding) (NNS affinities))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (ADJP (NN deep-learning) (VBN based)) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (VBZ uses) (NP (NP (RB only) (JJ sequence) (NN information)) (PP (IN of) (NP (DT both) (NNS targets) (CC and) (NNS drugs)))) (S (VP (TO to) (VP (VB predict) (NP (NNP DT) (NN interaction) (VBG binding) (NNS affinities)))))))))) (. .))
(S (NP (NP (DT The) (JJ few) (NNS studies)) (SBAR (WHNP (WDT that)) (S (VP (VBP focus) (PP (IN on) (NP (NNP DT) (VBG binding) (NN affinity) (NN prediction))))))) (VP (NN use) (NP (CC either) (NP (NP (CD 3D) (NNS structures)) (PP (IN of) (NP (NN protein-ligand) (NNS complexes)))) (CC or) (NP (NP (CD 2D) (NNS features)) (PP (IN of) (NP (NNS compounds)))))) (. .))
(S (NP (NP (CD One) (NN novel) (NN approach)) (VP (VBN used) (PP (IN in) (NP (DT this) (NN work))))) (VP (VBZ is) (NP (NP (DT the) (NN modeling)) (PP (IN of) (NP (NP (NN protein) (NNS sequences)) (CC and) (NP (NN compound) (CD 1D) (NNS representations)))) (PP (IN with) (NP (NP (JJ convolutional) (JJ neural) (NNS networks)) (PRN (-LRB- -LRB-) (NP (NNP CNNs)) (-RRB- -RRB-)))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (VBN proposed) (ADJP (NN deep) (VBG learning) (VBN based)) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (VBZ uses) (NP (NP (DT the) (CD 1D) (NNS representations)) (PP (IN of) (NP (NNS targets) (CC and) (NNS drugs)))))))) (VP (VBZ is) (NP (NP (DT an) (JJ effective) (NN approach)) (PP (IN for) (NP (NN drug) (NN target) (VBG binding) (NN affinity) (NN prediction)))))))) (. .))
(S (NP (NP (DT The) (NN model)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (JJ high-level) (NNS representations)) (PP (IN of) (NP (NP (DT a) (NN drug)) (CC and) (NP (DT a) (NN target))))) (VP (VBP are) (VP (VBN constructed) (PP (IN via) (NP (NNP CNNs)))))))) (VP (VBD achieved) (NP (NP (DT the) (JJS best) (NN Concordance) (NNP Index) (PRN (-LRB- -LRB-) (NNP CI) (-RRB- -RRB-)) (NN performance)) (PP (IN in) (NP (NP (CD one)) (PP (IN of) (NP (PRP$ our) (JJR larger) (NN benchmark) (NNS data) (NNS sets)))))) (, ,) (S (VP (VBG outperforming) (NP (NP (DT the) (NNP KronRLS) (NN algorithm)) (CC and) (NP (NP (NNP SimBoost)) (, ,) (NP (NP (DT a) (JJ state-of-the-art) (NN method)) (PP (IN for) (NP (NNP DT) (VBG binding) (NN affinity) (NN prediction))))))))) (. .))
